NAYA Biosciences Inc. (NAYA)
1.88
-0.38 (-16.81%)
At close: Apr 15, 2025, 3:59 PM
1.87
-0.55%
After-hours: Apr 15, 2025, 07:56 PM EDT
-16.81% (1D)
| Bid | 1.85 |
| Market Cap | 1.25M |
| Revenue (ttm) | 6.23M |
| Net Income (ttm) | -7.47M |
| EPS (ttm) | -12.12 |
| PE Ratio (ttm) | -0.16 |
| Forward PE | -0.58 |
| Analyst | Buy |
| Ask | 1.91 |
| Volume | 102,214 |
| Avg. Volume (20D) | 46,070 |
| Open | 1.95 |
| Previous Close | 2.26 |
| Day's Range | 1.86 - 2.18 |
| 52-Week Range | 1.38 - 42.00 |
| Beta | 2.04 |
About NAYA
INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body....
Industry Medical - Devices
Sector Healthcare
IPO Date Nov 2, 2020
Employees 30
Stock Exchange NASDAQ
Ticker Symbol NAYA
Website http://www.nayabiosciences.com
Analyst Forecast
According to 1 analyst ratings, the average rating for NAYA stock is "Buy." The 12-month stock price forecast is $24, which is an increase of 1176.60% from the latest price.
Stock Forecasts1 month ago
-33.77%
NAYA Biosciences shares are trading lower after th...
Unlock content with
Pro Subscription
3 months ago
-38.52%
NAYA Biosciences shares are trading lower after the company priced a 13,615,171 unit offering at $0.70/unit.